Arthritis in Dogs: Evidence-Based Treatment & Pain Management

Arthritis in dogs is not just a condition of old age, and it is certainly not something dogs simply have to endure. Canine osteoarthritis is a progressive, painful joint disease with a well-established pathophysiology, validated diagnostic tools, and an expanding range of effective treatments. The problem is not a lack of options—it is a lack of recognition. Because dogs hide pain instinctively, arthritis often advances significantly before owners notice anything more than "slowing down a bit." By the time a dog is visibly limping or struggling to rise, the joint damage has typically been building for months or years.

Understanding Osteoarthritis: What Is Happening in the Joint

Healthy joints are cushioned by smooth cartilage and lubricated by synovial fluid. In osteoarthritis, cartilage degenerates faster than it is replaced—due to age, previous injury, developmental abnormalities like hip dysplasia, obesity, or simply the accumulated mechanical stress of a working dog's career. As the cartilage thins, bone surfaces begin to contact each other. The joint capsule becomes inflamed, producing pain-sensitizing cytokines. Bony projections called osteophytes form at joint margins, further restricting movement and causing additional pain.

This is not a static process. Untreated osteoarthritis tends to worsen, and the pain itself causes central sensitization—a rewiring of pain pathways in the spinal cord that amplifies the pain signal even in the absence of additional joint damage. This is why early treatment matters: it prevents the pain state from becoming self-perpetuating.

Diagnosis: What to Expect at the Vet

Diagnosing arthritis involves a combination of physical examination, owner history, and imaging. During physical examination, a veterinarian will assess gait, range of motion in each joint, presence of crepitus (the grinding sensation of bone on bone), muscle symmetry, and pain response to joint manipulation. Radiographs (X-rays) are standard to confirm joint changes—osteophyte formation, joint space narrowing, and subchondral bone changes are all visible on X-ray. Advanced imaging (CT, MRI) is reserved for complex cases or surgical planning.

Validated pain assessment tools like the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire or the Canine Brief Pain Inventory (CBPI) allow owners to objectively score their dog's mobility and pain level before and after treatment, making it easier to track progress.

Pharmaceutical Pain Management

Medication forms the cornerstone of moderate-to-severe osteoarthritis management and should always be supervised by a veterinarian.

NSAIDs (Non-steroidal anti-inflammatory drugs): These are the most widely used and most effective first-line treatments for canine osteoarthritis. Veterinary-approved NSAIDs—including carprofen (Rimadyl), meloxicam, grapiprant, and deracoxib—reduce joint inflammation and pain substantially. They must not be combined with each other or with corticosteroids, and require regular blood monitoring to check liver and kidney function. Human NSAIDs (ibuprofen, naproxen) are toxic to dogs and must never be used.

Gabapentin: Originally an anticonvulsant, gabapentin is now widely used in veterinary medicine for neuropathic and chronic pain. It modulates calcium channels in pain pathways and is frequently used alongside NSAIDs in dogs with significant central sensitization. It causes sedation initially, which typically resolves within a week of use.

Amantadine: This NMDA receptor antagonist is used specifically to address central sensitization in dogs that have not responded fully to NSAIDs. It is typically added to a primary analgesic protocol rather than used alone.

Monoclonal antibody therapy (Librela/bedinvetmab): A significant advance in canine arthritis management, Librela is a monthly injectable monoclonal antibody that targets nerve growth factor (NGF), a key driver of arthritis pain. It offers analgesic effects comparable to NSAIDs with a different mechanism, making it a valuable option for dogs that cannot tolerate NSAIDs or require additional pain control.

Physical Therapy and Rehabilitation

Veterinary physiotherapy is one of the most underutilized yet evidence-supported tools in arthritis management. Physical rehabilitation can maintain and improve muscle mass, joint range of motion, proprioception, and weight-bearing—all of which decline in arthritic dogs and worsen pain through compensatory movement patterns.

Common rehabilitation modalities include:

• Hydrotherapy (underwater treadmill): The buoyancy of water allows exercise without full weight-bearing, enabling muscle building in a pain-minimized environment. Particularly valuable for dogs with hip and elbow osteoarthritis.
• Therapeutic ultrasound and laser therapy: Both modalities deliver tissue-level anti-inflammatory effects and have been shown to reduce pain and improve mobility in arthritic dogs when used as part of a comprehensive plan.
• Controlled exercise: Short, frequent leash walks on soft terrain—rather than long, infrequent efforts—help maintain mobility without flare-up. Swimming is excellent for dogs with access to safe water.

Weight Management: The Single Most Impactful Intervention

If a dog with osteoarthritis is overweight, weight reduction is the single most impactful intervention available. Every excess pound of body weight increases the load on weight-bearing joints by four to five pounds of force. A landmark study by Impellizeri et al. (2000) demonstrated that dogs with hip osteoarthritis showed significant reduction in lameness scores after weight loss alone, without any other treatment change. Weight management also reduces systemic inflammation, as adipose tissue is metabolically active and pro-inflammatory.

Joint Supplements: What the Evidence Says

Glucosamine and chondroitin: These are the most commonly used joint supplements. Evidence in dogs is mixed but generally supportive for mild-to-moderate cases, particularly with long-term use. They appear to support cartilage matrix synthesis and have a mild anti-inflammatory effect. They are safe for long-term use with minimal side effects.

Omega-3 fatty acids (EPA/DHA): Marine-sourced omega-3s have the strongest evidence base among nutraceuticals for canine arthritis. Multiple controlled trials demonstrate measurable improvements in lameness, weight-bearing, and mobility with high-dose fish oil supplementation.

Undenatured type II collagen (UC-II): A relatively newer supplement with promising trial data in dogs, UC-II appears to work by oral tolerance—modulating the immune response to collagen within the joint.

References

1. Gamble LJ, Boesch JM, Frye CW, et al. Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Front Vet Sci. 2018;5:165. PMID: 30083539.
2. Impellizeri JA, Tetrick MA, Muir P. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. J Am Vet Med Assoc. 2000;216(7):1089–1091. PMID: 10750198.